Influence of Different Antiseizure Medications on Vascular Risk Factors in Children with Epilepsy

Doaa M Mahrous1, Asmaa N Moustafa1, Mahmoud M Higazi2

  • 1Department of Pediatrics, Faculty of Medicine, Minia University, Minia 61519, Egypt.

Insights

Prolonged use of older antiseizure medications or polytherapy in children significantly elevates homocysteine levels and cardiovascular disease risk. Newer medications appear safer, suggesting a need for monitoring and early intervention.

Area of Science:

  • Pediatric Neurology
  • Cardiovascular Health
  • Pharmacology

Background:

  • Elevated plasma homocysteine is linked to prolonged antiseizure medication (ASM) use.
  • Increased homocysteine is associated with carotid intima media thickness, raising atherosclerosis risk in young individuals.

Purpose of the Study:

  • To evaluate serum homocysteine levels in epileptic children on long-term ASMs.
  • To determine the association between homocysteine levels and cardiovascular disease risk in these children.

Main Methods:

  • Study included 60 epileptic children (2-15 years) and 25 healthy controls.
  • Assessed serum homocysteine, lipid profile, carotid intima media thickness (CIMT), and carotid stiffness.
  • Compared outcomes between children on old-generation ASMs, new-generation ASMs, polytherapy, and controls.

Main Results:

  • Significantly higher homocysteine, CIMT, and carotid stiffness were observed in children on old-generation ASMs and polytherapy compared to new-generation ASMs and controls.
  • Epileptic children on older ASMs or polytherapy face increased cardiovascular disease risk.

Conclusions:

  • Long-term use of old-generation ASMs and polytherapy in epileptic children is associated with elevated homocysteine and cardiovascular risk factors.
  • Regular monitoring and early intervention are crucial for epileptic children on specific ASM regimens.

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
555
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
410
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
806
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
246
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
538
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
248